Skaga, E., Kulesskiy, E., Brynjulvsen, M., Sandberg, C. J., Potdar, S., Langmoen, I. A., . . . Vik-Mo, E. O. (2019). Feasibility study of using high-throughput drug sensitivity testing to target recurrent glioblastoma stem cells for individualized treatment. Wiley.
Chicago-stil citatSkaga, Erlend, et al. Feasibility Study of Using High-throughput Drug Sensitivity Testing to Target Recurrent Glioblastoma Stem Cells for Individualized Treatment. Wiley, 2019.
MLA-referensSkaga, Erlend, et al. Feasibility Study of Using High-throughput Drug Sensitivity Testing to Target Recurrent Glioblastoma Stem Cells for Individualized Treatment. Wiley, 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.